44 related articles for article (PubMed ID: 9339824)
1. Behavioral and neurochemical effects of acute and repeated administration of triadimefon in the male rat.
Ikaiddi MU; Akunne HC; Soliman KF
Neurotoxicology; 1997; 18(3):771-80. PubMed ID: 9339824
[TBL] [Abstract][Full Text] [Related]
2. Development of behavioral sensitization to the cocaine-like fungicide triadimefon is prevented by AMPA, NMDa, DA D1 but not DA D2 receptor antagonists.
Reeves R; Thiruchelvam M; Cory-Slechta DA
Toxicol Sci; 2004 May; 79(1):123-36. PubMed ID: 15014204
[TBL] [Abstract][Full Text] [Related]
3. The neurochemical basis for the behavioral effects of triadimefon.
Hill D; Ikaiddi M; Mazzio E; Soliman KF
Ann N Y Acad Sci; 2000 Sep; 914():336-53. PubMed ID: 11085334
[TBL] [Abstract][Full Text] [Related]
4. Effects of triadimefon on extracellular dopamine, DOPAC, HVA and 5-HIAA in adult rat striatum.
Gagnaire F; Micillino JC
Toxicology; 2006 Jan; 217(2-3):91-104. PubMed ID: 16246478
[TBL] [Abstract][Full Text] [Related]
5. Expression of behavioral sensitization to the cocaine-like fungicide triadimefon is blocked by pretreatment with AMPA, NMDA and DA D1 receptor antagonists.
Reeves R; Thiruchelvam M; Cory-Slechta DA
Brain Res; 2004 May; 1008(2):155-67. PubMed ID: 15145752
[TBL] [Abstract][Full Text] [Related]
6. Behavioral sensitization and long-term neurochemical alterations associated with the fungicide triadimefon.
Reeves R; Thiruchelvam M; Richfield EK; Cory-Slechta DA
Pharmacol Biochem Behav; 2003 Sep; 76(2):315-26. PubMed ID: 14592684
[TBL] [Abstract][Full Text] [Related]
7. The effect of developmental exposure to the fungicide triadimefon on behavioral sensitization to triadimefon during adulthood.
Reeves R; Thiruchelvam M; Richfield EK; Cory-Slechta DA
Toxicol Appl Pharmacol; 2004 Oct; 200(1):54-63. PubMed ID: 15451308
[TBL] [Abstract][Full Text] [Related]
8. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
Hu XT; White FJ
Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
[TBL] [Abstract][Full Text] [Related]
9. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice.
Lin Z; Dodd CA; Filipov NM
Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127
[TBL] [Abstract][Full Text] [Related]
10. The herbicide glyphosate causes behavioral changes and alterations in dopaminergic markers in male Sprague-Dawley rat.
Hernández-Plata I; Giordano M; Díaz-Muñoz M; Rodríguez VM
Neurotoxicology; 2015 Jan; 46():79-91. PubMed ID: 25522657
[TBL] [Abstract][Full Text] [Related]
11. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
[TBL] [Abstract][Full Text] [Related]
12. Triadimefon and triadimenol: effects on monoamine uptake and release.
Walker QD; Mailman RB
Toxicol Appl Pharmacol; 1996 Aug; 139(2):227-33. PubMed ID: 8806838
[TBL] [Abstract][Full Text] [Related]
13. Changes in the central dopaminergic systems in the streptozotocin-induced diabetic rats.
Lim DK; Lee KM; Ho IK
Arch Pharm Res; 1994 Dec; 17(6):398-404. PubMed ID: 10319147
[TBL] [Abstract][Full Text] [Related]
14. Selective stimulation of serotonin2c receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration.
Di Matteo V; Pierucci M; Esposito E
J Neurochem; 2004 Apr; 89(2):418-29. PubMed ID: 15056285
[TBL] [Abstract][Full Text] [Related]
15. [Effects of antagonists of NMDA receptor on methamphetamine-induced decrease in the dopamine uptake sites in the rat striatum and on the behavioral sensitization].
Muraki A
Hokkaido Igaku Zasshi; 1993 May; 68(3):407-18. PubMed ID: 8319937
[TBL] [Abstract][Full Text] [Related]
16. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.
Pugsley TA; Davis MD; Akunne HC; MacKenzie RG; Shih YH; Damsma G; Wikstrom H; Whetzel SZ; Georgic LM; Cooke LW
J Pharmacol Exp Ther; 1995 Dec; 275(3):1355-66. PubMed ID: 8531103
[TBL] [Abstract][Full Text] [Related]
17. CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.
Rugsley TA; Davis MD; Akunne HC; Cooke LW; Whetzel SZ; MacKenzie RG; Shih YH; van Leeuwen DH; DeMattos SB; Georgic LM
J Pharmacol Exp Ther; 1995 Aug; 274(2):898-911. PubMed ID: 7636753
[TBL] [Abstract][Full Text] [Related]
18. Prenatal cocaine exposure affects postnatal dopaminergic systems in various regions of the rat brain.
Choi SJ; Mazzio E; Kolta MG; Soliman KF
Ann N Y Acad Sci; 1998 May; 844():293-302. PubMed ID: 9668686
[TBL] [Abstract][Full Text] [Related]
19. Dopamine and serotonin release-regulating autoreceptor sensitivity in A9/A10 cell body and terminal areas after withdrawal of rats from continuous infusion of cocaine.
Chen NH; Reith ME
J Pharmacol Exp Ther; 1993 Dec; 267(3):1445-53. PubMed ID: 8263807
[TBL] [Abstract][Full Text] [Related]
20. Early administration of tiapride to young rats without long-lasting changes in the development of the dopaminergic system.
Bock N; Moll GH; Wicker M; Pilz J; Rüther E; Banaschewski T; Huether G; Rothenberger A
Pharmacopsychiatry; 2004 Jul; 37(4):163-7. PubMed ID: 15467972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
